Delta-Fly Pharma(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4598/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/11/11 | 日証協 | 260,800株 | -1.36% | 52,500株 | -37.5% | 752,041株 | -1.63% | 54,400株 | +1.87% |
2022/11/04 | 日証協 | 264,400株 | -3.5% | 84,000株 | +106.9% | 764,541株 | -0.51% | 53,400株 | +790% |
2022/10/28 | 日証協 | 274,000株 | +0.51% | 40,600株 | +915% | 768,441株 | -1.71% | 6,000株 | -41.75% |
2022/10/21 | 日証協 | 272,600株 | -5.51% | 4,000株 | -74.03% | 781,841株 | -1.16% | 10,300株 | -31.33% |
2022/10/14 | 日証協 | 288,500株 | -33.8% | 15,400株 | -1.28% | 791,041株 | +0.85% | 15,000株 | -24.62% |
2022/10/07 | 日証協 | 435,800株 | -4.83% | 15,600株 | -84.18% | 784,341株 | +10.02% | 19,900株 | -18.13% |
2022/09/30 | 日証協 | 457,900株 | -0.24% | 98,600株 | +9999.99% | 712,937株 | -9.9% | 24,306株 | -40.87% |
2022/09/22 | 日証協 | 459,000株 | +48.02% | 200株 | -99.88% | 791,231株 | -0.25% | 41,104株 | -39.82% |
2022/09/16 | 日証協 | 310,100株 | -9.46% | 170,400株 | +399.71% | 793,231株 | -3.15% | 68,302株 | -49.56% |
2022/09/09 | 日証協 | 342,500株 | -17.05% | 34,100株 | -43.91% | 819,029株 | +4.2% | 135,400株 | +624.06% |
2022/09/02 | 日証協 | 412,900株 | -8.69% | 60,800株 | -70.76% | 786,029株 | -1.63% | 18,700株 | -80.48% |
2022/08/26 | 日証協 | 452,200株 | -13.22% | 207,900株 | -40.89% | 799,029株 | -13.42% | 95,800株 | +53.53% |
2022/08/19 | 日証協 | 521,100株 | -10.39% | 351,700株 | +868.87% | 922,829株 | -5.67% | 62,400株 | +27.35% |
2022/08/12 | 日証協 | 581,500株 | -6.24% | 36,300株 | -91.92% | 978,329株 | -2.67% | 49,000株 | -71.23% |
2022/08/05 | 日証協 | 620,200株 | +5.39% | 449,300株 | +12.32% | 1,005,129株 | +4.94% | 170,300株 | +2.41% |
2022/07/29 | 日証協 | 588,500株 | +4.59% | 400,000株 | +76.21% | 957,829株 | -0.03% | 166,300株 | +43.24% |
2022/07/22 | 日証協 | 562,700株 | -3.6% | 227,000株 | +2.34% | 958,129株 | -1.71% | 116,100株 | +196.17% |
2022/07/15 | 日証協 | 583,700株 | -5.12% | 221,800株 | +209.78% | 974,829株 | -2.1% | 39,200株 | -24.18% |
2022/07/08 | 日証協 | 615,200株 | -6.73% | 71,600株 | -54.65% | 995,729株 | -1.62% | 51,700株 | +29.23% |
※株式分割は考慮していませんのでご注意ください。
Page Top